52
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      COVID-19 and Neonatal Resuscitation

      editorial
      * ,
      Neonatology
      S. Karger AG

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this issue of Neonatology, we publish two papers with suggestions for neonatal resuscitation when the mother is suspected of having COVID-19 infection [1, 2]. These papers come from Italy [1] where the COVID-19 pandemic has resulted in many thousands of deaths and from Hong Kong [2] where, in contrast, only 4 lives to date have been lost to the infection. These differences in outcomes between Europe and Asia will need to be explored in future research studies taking into account demographic factors [3] as well as government and medical responses. There is uncertainty about whether the COVID-19 virus can be transmitted vertically from mother to newborn infant either in utero or at birth. Although vertical transmission seems unlikely, there have been reports of early neonatal infection [4, 5]. Zhu et al. [4] reported some adverse outcomes in 10 babies born to mothers with COVID-19 infection. These adverse outcomes included fetal distress, premature labor, respiratory distress, thrombocytopenia and abnormal liver function, but the neonates themselves tested negative for the virus. It is likely that vertical transmission of the virus did not occur, and the neonatal complications were related to preterm delivery [4]. Zhang et al. [5] in a very recent report could only find 4 infected newborns in China and they presented aged between 30 h and 17 days after birth suggesting nosocomial infection. These babies had mild or no illness, none needed intensive care, and all seemed to have recovered. Three of the infants had been separated from their mother right after birth and were not breastfed [5]. We hope that you find the recommendations contained in these thoughtful reports from Italy [1] and Hong Kong [2] useful and helpful in planning perinatal care for infants at risk of developing COVID-19 infection. We wish all our readers well in their efforts to combat the effects of this terrible pandemic and salute all those healthcare workers in their dedication to the task. We are convinced that solutions will be found to overcome this deadly virus.

          Related collections

          Most cited references5

          • Record: found
          • Abstract: found
          • Article: not found

          Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia

          The newly identified 2019-nCoV, which appears to have originated in Wuhan, the capital city of Hubei province in central China, is spreading rapidly nationwide. A number of cases of neonates born to mothers with 2019-nCoV pneumonia have been recorded. However, the clinical features of these cases have not been reported, and there is no sufficient evidence for the proper prevention and control of 2019-nCoV infections in neonates.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Novel Coronavirus Infection in Newborn Babies Under 28 Days in China

            The outbreak of coronavirus disease 2019 (Covid-19) spreads rapidly [1–8]. On January 31, the World Health Organization declared Covid-19 a public health emergency of international concern. By March 13, Covid-19 have been confirmed in 127 countries with 145,166 cases and 5,428 deaths worldwide.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found

              Neonatal Resuscitation Where the Mother Has a Suspected or Confirmed Novel Coronavirus (SARS-CoV-2) Infection: Suggestion for a Pragmatic Action Plan

              Coronavirus disease 2019 (COVID-19), caused by the novel SARS-CoV-2 virus, is rapidly spreading across the world. As the number of infections increases, those of infected pregnant women and children will rise as well. Controversy exists whether COVID-19 can be transmitted in utero and lead to disease in the newborn. As this chance cannot be ruled out, strict instructions for the management of mothers and newborn infants are mandatory. This perspective aims to be a practical support tool for the planning of delivery and neonatal resuscitation of infants born by mothers with suspected or confirmed COVID-19 infection.
                Bookmark

                Author and article information

                Journal
                NEO
                Neonatology
                10.1159/issn.1661-7800
                Neonatology
                S. Karger AG
                1661-7800
                1661-7819
                23 April 2020
                :
                :
                : 1
                Author notes
                *Henry L. Halliday, E-Mail henry.halliday@doctors.org.uk
                Article
                508003 Neonatology
                10.1159/000508003
                32325458
                36808107-2f23-4239-8c81-65ad624dac99
                © 2020 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 19 April 2020
                : 20 April 2020
                Page count
                Pages: 1
                Categories
                Editorial Note

                Internal medicine,Respiratory medicine,Clinical Psychology & Psychiatry,Microbiology & Virology,Infectious disease & Microbiology

                Comments

                Comment on this article